|
Volumn 91, Issue 9, 1996, Pages 1758-1765
|
Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATTAPULGITE;
LANSOPRAZOLE;
OMEPRAZOLE;
PLACEBO;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE CONTROL;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
ELECTROCARDIOGRAM;
GASTRIN BLOOD LEVEL;
HUMAN;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REFLUX ESOPHAGITIS;
STOMACH BIOPSY;
TREATMENT PLANNING;
WOUND HEALING;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
ENZYME INHIBITORS;
ESOPHAGITIS, PEPTIC;
FEMALE;
FOLLOW-UP STUDIES;
GASTRIC MUCOSA;
GASTRINS;
H(+)-K(+)-EXCHANGING ATPASE;
HISTAMINE H2 ANTAGONISTS;
HUMANS;
MALE;
MIDDLE AGED;
OMEPRAZOLE;
RECURRENCE;
TIME FACTORS;
|
EID: 0029846896
PISSN: 00029270
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (69)
|
References (2)
|